HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nifekalant hydrochloride for patients with cardiac arrest caused by shockable rhythm.

AuthorsKen Nagao
JournalCirculation journal : official journal of the Japanese Circulation Society (Circ J) Vol. 74 Issue 11 Pg. 2285-7 (Nov 2010) ISSN: 1347-4820 [Electronic] Japan
PMID20962421 (Publication Type: Comment, Editorial)
Chemical References
  • Anti-Arrhythmia Agents
  • Pyrimidinones
  • nifekalant
Topics
  • Anti-Arrhythmia Agents (administration & dosage)
  • Defibrillators
  • Electric Countershock (instrumentation)
  • Humans
  • Out-of-Hospital Cardiac Arrest (drug therapy, etiology, mortality, therapy)
  • Patient Admission
  • Pyrimidinones (administration & dosage)
  • Survival Rate
  • Tachycardia, Ventricular (complications, drug therapy, mortality, therapy)
  • Time Factors
  • Torsades de Pointes (chemically induced)
  • Treatment Failure
  • Ventricular Fibrillation (complications, drug therapy, mortality, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: